-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
In This Section
-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
News
-
Medical Diagnostics Patent Eligibility Still Unsettled
July 8, 2019
A split US Court of Appeals for the Federal Circuit, on July 3, 2019, refused to revisit their February decision to invalidate a patent licensed to Quest Diagnostics Inc.’s Athena unit for a way to diagnose a severe neurological disorder. -
New USPTO Trademark Examination Guidance
July 5, 2019
The US Patent and Trademark Office on June 3, 2019, published an examination guide explaining how the USPTO will examine trademark applications following the Supreme Court’s recent decision in Iancu v. Brunetti. -
USPTO Rule Requires US Attorney for Foreign Trademark Applicants
July 3, 2019
The US Patent and Trademark Office on July 2, 2019, issued final rules requiring foreign-domiciled trademark applicants, registrants, and parties to Trademark Trial and Appeal Board proceedings to be represented by an attorney who is licensed to practice law in the United States. -
New TBMP Available
July 1, 2019
The June 2019 update of the USPTO’s Trademark Trial and Appeal Board Manual of Procedure (TBMP) is now available on the Trademark Trial and Appeal Board webpage under "Policies and procedures. -
Federal Circuit Finds Cellspin Data Transfer Patents Abstract but Valid
July 1, 2019
On June 25, 2019, the Federal Circuit held that a trial court wrongly dismissed Cellspin Soft, Inc.’s (Cellspin), patent infringement lawsuits after determining that the four disputed patents were invalid and covered an abstract idea.